1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67D5BD1B8BB6B0B5D65257F4D004C7B28
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/7D5BD1B8BB6B0B5D65257F4D004C7B28!OpenDocument
18
19OpenDocument
2018.207.129.175
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Product Launch Excellence

Document Excerpt: Resourcing a Successful Product Launch: Activity Investments

DB Image

ID: MD-498


Features:

7 Info Graphics

27 Data Graphics

1000+ Metrics


Pages/Slides: 4


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".

To return to the study abstract to purchase the full study - click here


This excerpt includes research findings and metrics from document #5397 "Resourcing a Successful Product Launch: Activity Investments."


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Medical Device; Manufacturing; Biotech; Consumer Products; Chemical


Companies Profiled:
Abbott; Cutanea Life Sciences; Abbvie; Pharmacyclics; Astellas; Sebela; Baxter Healthcare; Bayer; Boehringer Ingelheim; EMD Serono; Nektar Therapeutics; Grunenthal; Inspire Pharmaceuticals; Lundbeck; GlaxoSmithKline ; Novartis; Noven Therapeuticals; Novo Nordisk; Regeneron; Roche; Servier; Shire; Teva Pharmaceutical Industries Ltd; Zydus Cadila; Genentech; Lilly

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.